Supplementary Figures 1-4 from Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

Authors:
  • JTJeffrey W. Tyner
    Jeffrey W. Tyner
  • WYWayne F. Yang
    Wayne F. Yang
  • ABArmand Bankhead
    Armand Bankhead
  • GFGuang Fan
    Guang Fan
  • LFLuke B. Fletcher
    Luke B. Fletcher
  • JBJade Bryant
    Jade Bryant
  • JGJason M. Glover
    Jason M. Glover
  • BCBill H. Chang
    Bill H. Chang
  • SSStephen E. Spurgeon
    Stephen E. Spurgeon
  • WFWilliam H. Fleming
    William H. Fleming
  • TKTibor Kovacsovics
    Tibor Kovacsovics
  • JGJason R. Gotlib
    Jason R. Gotlib

Abstract
PDF file - 2.3MB, (S1) Scheme for profiling leukemia patient samples with a panel of kinase inhibitors; (S2) Rank ordering of 151 sample IC50 values for each small-molecule kinase inhibitor; (S3) One-way clustering of leukemia patient sample response to small-molecule kinase inhibitors; (S4) Two-way clustering of leukemia patient sample response to small-molecule kinase inhibitors